Selectis Health, Inc 8-K, filed May 26, 2021
Selectis Health, Inc. (GBCS)
About this 8-K
Selectis Health, Inc filed this 8-K on May 26, 2021, reporting on events of May 24, 2021.
Items reported
- Item 5.07: Shareholder vote results
UNITEDSTATESSECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM8-K
CURRENTREPORT
Pursuantto Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 24, 2021
GLOBALHEALTHCARE REIT, INC.****(Exact Name of Registrant as Specified in its Charter)
| Utah | 0-15415 | 87-0340206 |
|---|---|---|
| (State<br>or other jurisdiction<br><br> <br>of incorporation) | Commission<br><br> <br>FileNumber | (I.R.S.<br> Employer<br><br> <br>Identification<br> number) |
8480 E. Orchard Road, Ste. 4900, Greenwood Village, CO 80111
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (720) 680-0808
(Former name or former address, if changed since last report)
| [ ] | Written<br> communications pursuant to Rule 425 under the Securities Act |
|---|---|
| [ ] | Soliciting<br> material pursuant to Rule 14a-12 under the Exchange Act |
| [ ] | Pre-commencement<br> communications pursuant to Rule 14d-2(b) under the Exchange Act |
| [ ] | Pre-commencement<br> communications pursuant to Rule 13e-4(c) under the Exchange Act |
Securitiesregistered pursuant to Section 12(b) of the Act:
| Title of each Class | Trading Symbol | Name of each exchange on which registered |
|---|---|---|
| N/A | N/A | N/A |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [X]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
| ITEM 5.07 | SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS |
|---|
On May 24, 2021, Global Healthcare REIT, Inc. a Utah corporation (the “Company”) convened its Annual Meeting of Stockholders. As of the record date of the meeting, April 8, 2021, there were 26,866,379 shares of common stock issued and outstanding and eligible to vote at the meeting. At the meeting, an aggregate of 15,314,805 shares were present, either in person or by proxy, which constituted a quorum for the meeting.
Following are the results of the matters voted on by Stockholders at the Annual Meeting as certified by the Final Report of the Inspector of Election.
GLOBALHEALTHCARE REIT, INC.
2021 Annual Meeting of Stockholders
May 24, 2021
Final Report of the Inspector of Election
I, the undersigned, the duly appointed Inspector of Election at the Annual Meeting of Stockholders (the “Meeting”) of Global Healthcare REIT, Inc. (the “Company”), held on May 24, 2021 hereby certify that:
| 1) | Before<br> entering upon the discharge of my duties as Inspector of Election at the Meeting, I took and signed an Oath of Inspector of<br> Election. | |||
|---|---|---|---|---|
| 2) | The<br> Meeting was held online at www.virtualshareholdermeeting.com/GBCS2021, pursuant to notice duly given. | |||
| 3) | At<br> the close of business on April 8, 2021, the record date for the determination of shareholders entitled to vote at the Meeting,<br> there were 26,866,379 outstanding shares of the Company’s Common Stock, each share being entitled to one vote, constituting<br> all of the outstanding voting securities of the Company. | |||
| 4) | At<br> the Meeting, the holders of 15,314,805 shares of the Company’s Common Stock were represented in person or by proxy constituting<br> a quorum. | |||
| 5) | The<br> undersigned canvassed the votes of the stockholders cast by ballot, proxy and on-line on the matters presented at the Meeting. | |||
| 6) | At<br> the Meeting, the vote on the proposal to elect 4 directors named in the Proxy, was as follows: | |||
| FOR | WITHHOLD | BROKER<br> NON-VOTE | ||
| --- | --- | --- | --- | --- |
| Clifford<br> Neuman | Class<br> I Director | 11,117,569 | 2,480,624 | 1,716,612 |
| Adam<br> Desmond | Class<br> II Director | 13,113,599 | 484,594 | 1,716,612 |
| Lance<br> Baller | Class<br> III Director | 13,100,599 | 497,594 | 1,716,612 |
| Christopher<br> R. Barker | Class<br> III Director | 13,100,609 | 497,584 | 1,716,612 |
| 7) | At<br> the Meeting, to ratify the appointment of Malone Bailey LLP as our independent registered public accounting firm for the fiscal<br> year ending December 31, 2021, was as follows: | |||
| --- | --- | |||
| FOR | AGAINST | ABSTAIN | BROKER<br> NON-VOTE | |
| --- | --- | --- | --- | |
| 15,303,491 | 786 | 10,528 | 0 | |
| 8) | At<br> the Meeting, the vote to approve the advisory vote of the Company’s Executive Compensation (Say-on-Pay), was as follows: | |||
| --- | --- | |||
| FOR | AGAINST | ABSTAIN | BROKER<br> NON-VOTE | |
| --- | --- | --- | --- | |
| 13,335,129 | 144,634 | 118,430 | 1,716,612 | |
| 9) | At<br> the Meeting, the vote to approve the advisory vote on the frequency of a shareholder vote on Executive Compensation (Say-on-<br> Frequency), was as follows: | |||
| --- | --- | |||
| ONE<br> YEAR | TWO<br> YEARS | THREE<br> YEARS | ABSTAIN | BROKER<br> NON-VOTE |
| --- | --- | --- | --- | --- |
| 1,615,072 | 8,471,613 | 3,443,608 | 67,900 | 1,716,612 |
| 10) | At<br> the Meeting, the vote to approve our proposed Second Amended and Restated Articles of Incorporation, was as follows: | |||
| --- | --- | |||
| FOR | AGAINST | ABSTAIN | BROKER<br> NON-VOTE | |
| --- | --- | --- | --- | |
| 13,098,881 | 420,690 | 78,622 | 1,716,612 | |
| 11) | At<br> the Meeting, the vote to approve a reverse stock split of our Common Stock by a ratio of up to one-for-twelve, was as follows: | |||
| --- | --- | |||
| FOR | AGAINST | ABSTAIN | BROKER<br> NON-VOTE | |
| --- | --- | --- | --- | |
| 14,349,156 | 857,697 | 107,952 | 0 | |
| 12) | At<br> the Meeting, the vote to approve our 2021 Selectis Health Equity Incentive Plan, was as follows: | |||
| --- | --- | |||
| FOR | AGAINST | ABSTAIN | BROKER<br> NON-VOTE | |
| --- | --- | --- | --- | |
| 13,120,407 | 467,226 | 10,560 | 1,716,612 |
IN WITNESS WHEREOF, I have made this Final Report and have hereunto set my hand this 24^TH^ day of May 2021.
| /s/ Louis D. Larsen |
|---|
| Louis<br> D. Larsen |
| Broadridge<br> Representative |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Global Healthcare REIT, Inc.<br><br> <br>(Registrant) | |
|---|---|
| Dated:<br> May 26, 2021 | /s/ Lance Baller |
| Lance<br> Baller, CEO |